We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

Mindray offers a range of chemistry and hematology analyzers, designed to meet the needs of smaller labs as a main in... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
03 Mar 2021 - 05 Mar 2021
Virtual Venue
06 Mar 2021 - 10 Mar 2021
Virtual Venue

Quantitative Agglutination Determined on Automatic Hematology Analyzer

By LabMedica International staff writers
Posted on 16 Sep 2020
Print article
Image: The Mindray BC-2800 Fully Automatic Hematology Analyzer with 19 Parameters for CBC /Blood Cell Test for Hospital Use (Photo courtesy of Mindray).
Image: The Mindray BC-2800 Fully Automatic Hematology Analyzer with 19 Parameters for CBC /Blood Cell Test for Hospital Use (Photo courtesy of Mindray).
The currently available agglutination identification methods are slide methods and test tube methods. Based on the distribution, uniformity and comprehensive changes of non-aggregated cells and agglutinating cells in the liquid, the agglutination degree and strength can be determined by the naked eye.

The results are subject to the subjective influence of the observers, and it has been shown that the amount of agglutination determined in the same sample by different people and the determination of the same sample by the same person at different times were significantly different, thus affecting the accuracy and reliability of the study.

Medical Laboratorians at the Dalian Medical University (Dalian, China) selected and diluted Type A serum to react with the type B cells and the normal saline group was used as the control group. A red blood cell (RBC) count was performed using an automatic hematology analyzer (Mindray, Shenzhen, China), after incubation in a warm bath for 30 minutes. The degree of agglutination on the glass slide was also recorded. A positive serum of antinuclear antibody (ANA) was collected and RBC agglutination between RBC-O and ANA positive serum was determined using the automatic hematology analyzer method.

The scientists reported that the relationship between the results from the automatic hematology analyzer and the agglutination strength using the glass slide method was determined and showed that there was a good linear relationship between the agglutination index (AGI) and serum antibody concentration. There was a significant difference between the serum of ANA positive patients and the normal control group. The stability test results showed a coefficient of variation (CV) < 10% when using the automatic hematology analyzer, indicating that the reproducibility of the test was good.

The investigators found that when normal human serum (control group) was mixed with red blood cells the value was lower than when mixed with normal saline (AGI). Furthermore, the analysis found that the AGI value was normally distributed, so they believe that healthy donors are likely to have a low level of resistance to RBC antibody. This shows that the automatic hematology analyzer can detect weak agglutination antibody in serum, but classical methods cannot observe this phenomenon.

The authors concluded that the automatic hematology analyzer can not only effectively detect the agglutination antibody in serum, but also provides a new tool for clinical application to detect agglutination with high sensitivity, and is quantitative, objective and accurate. The study has been available online since July 3, 2020 in the journal Clinica Chimica Acta.

Gold Supplier
Streptococcus Test
COVID-19 Anitibody Test
SGTi-flex COVID-19 IgM/IgG
SARS-CoV-2/Influenza A & B/RSV Test
BIOSYNEX® AMPLIQUICK® SARS-COV-2 and Respiratory Triplex
COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

Print article


Molecular Diagnostics

view channel
Image: Micrograph of a colorectal adenocarcinoma (Photo courtesy of Wikimedia Commons)

Plasma or Urine Liquid Biopsy Tests May Guide Colorectal Cancer Treatment

A recent paper suggested that liquid biopsy examination of blood or urine could aid in evaluating the effectiveness of therapy for colorectal cancers that had begun to metastasize beyond the site of the... Read more


view channel
Image: Sysmex CN-Series automated blood coagulation analyzer (Photo courtesy of Sysmex Corporation)

Siemens and Sysmex Extend Agreement to Provide One of the Largest Portfolios of Hemostasis Testing Systems and Reagents

Siemens Healthineers (Erlangen, Germany) and Sysmex Corporation (Kobe, Japan) have renewed their long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.